chr15-41901007-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000220325.9(EHD4):c.1264G>A(p.Glu422Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000727 in 1,608,510 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000220325.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EHD4 | NM_139265.4 | c.1264G>A | p.Glu422Lys | missense_variant | 6/6 | ENST00000220325.9 | NP_644670.1 | |
EHD4 | XM_047432408.1 | c.1000G>A | p.Glu334Lys | missense_variant | 6/6 | XP_047288364.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EHD4 | ENST00000220325.9 | c.1264G>A | p.Glu422Lys | missense_variant | 6/6 | 1 | NM_139265.4 | ENSP00000220325 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152222Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000885 AC: 22AN: 248560Hom.: 0 AF XY: 0.0000818 AC XY: 11AN XY: 134414
GnomAD4 exome AF: 0.0000700 AC: 102AN: 1456170Hom.: 0 Cov.: 32 AF XY: 0.0000664 AC XY: 48AN XY: 723394
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152340Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74492
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 18, 2023 | The c.1264G>A (p.E422K) alteration is located in exon 6 (coding exon 6) of the EHD4 gene. This alteration results from a G to A substitution at nucleotide position 1264, causing the glutamic acid (E) at amino acid position 422 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at